Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 1 | +584K | 57.9% | $17.13 | +$10M |
Sells | 6 | -425K | 42.1% | $17.88 | -$7.59M |
Net | -5 | +159K | 15.8% | +$2.41M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Dennis D. Kim | Chief Medical Officer | $474K | Apr 13, 2023 | ||
Charles McWherter | President of R&D | $0 | -$1.55M | -100% | Mar 22, 2024 |
Robert James Wills | Director | $0 | Mar 22, 2024 | ||
Paul Quinlan | General Counsel | $0 | -$1.28M | -100% | Mar 22, 2024 |
Klara Dickinson | Chief Regulatory Officer | $0 | Mar 22, 2024 | ||
Harish Shantharam | Chief Financial Officer | $0 | Mar 22, 2024 | ||
Janet Dorling | Director | $0 | -$562K | -100% | Mar 22, 2024 |
Sujal Shah | Chief Executive Officer, Director | $0 | -$3.25M | -100% | Mar 22, 2024 |
Kurt Von Emster | Director | $0 | -$250K | -100% | Mar 22, 2024 |
Daniel Menold | Vice President, Finance | -$708K | Jan 16, 2024 | ||
Thomas G. Wiggans | Director | Mar 22, 2024 | |||
Caroline M. Loewy | Director | Mar 22, 2024 | |||
Lewis J. Stuart | Chief Commercial Officer | Jan 25, 2023 | |||
Avoro Capital Advisors LLC | 10%+ Owner | +$10M | Sep 12, 2023 | ||
Eric Lefebvre | Director | Mar 22, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|